...
首页> 外文期刊>Cancer immunology, immunotherapy : >Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours
【24h】

Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours

机译:甘露糖结合凝集素(MBL)和MBL相关的丝氨酸蛋白酶-2(MASP-2),患有恶性和良性卵巢肿瘤的妇女

获取原文
获取原文并翻译 | 示例

摘要

Mannose-Binding Lectin (MBL) is a serum pattern recognition molecule, able to activate complement in association with MASP proteases. Serum levels of MBL and MASP-2, activities of MBL-MASP complexes, single nucle-otide polymorphisms of the MBL2 and MASP2 genes and/ or their specific mRNA expression in ovarian sections were investigated in 128 patients suffering from primary ovarian cancer (OC) and compared with 197 controls (C), encompassing both patients with benign ovarian tumours (n = 123) and others with no ovarian pathology in - 74). MBL deficiency-associated genotypes were more common among OC patients than among controls. The O/O group of genotypes was associated with ovarian cancer (OR 3.5, p = 0.02).
机译:甘露糖结合凝集素(MBL)是一种血清图案识别分子,能够与MASP蛋白酶联合激活补体。 MBL和MASP-2的血清水平,MBL-MASP复合物的活性,MBL2和MASP2基因的单核斑块多态性和/或它们在卵巢切片中的特异性mRNA表达,128例患有原发性卵巢癌(OC) 与197(c)相比,包括良性卵巢肿瘤(n = 123)的患者和其他没有卵巢病理的患者 - 74)。 在OC患者中,MBL缺乏相关的基因型比对照组更常见。 O / O基因型组与卵巢癌(或3.5,P = 0.02)有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号